Strengthening the case for global risk assessment of patients with high blood pressure

American Journal of Hypertension

Volumn 22, Issue 1, 2009, Pages 9-

  Sharman, James E ^a   Prins, Johannes B ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

BLOOD PRESSURE; CARDIOVASCULAR RISK; DYSLIPIDEMIA; EXERCISE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; WEIGHT REDUCTION;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; HUMANS; INSULIN RESISTANCE; PREVALENCE; RISK ASSESSMENT; RISK FACTORS;

EID: 57749168438     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2008.284     Document Type: Note

References (5)

1. Henry RMA, Kostense PJ, Spijkerman AMW, Dekker JM, Nijpels G, Heine RJ, Kamp O, Westerhof N, Bouter LM, Stehouwer CDA. Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study. Circulation 2003; 107:2089-2095.
2. Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996; 275:1571-1576.
3. Sheu WH, Jeng CY, Shieh SM, Fuh MM, Shen DD, Chen YD, Reaven GM. Insulin resistance and abnormal electrocardiograms in patients with high blood pressure. Am J Hypertens 1992; 5:444-448.
4. Lima NKC, Abbasi F, Lamendola C, Reaven GM. Prevalence of insulin resistance and related risk factors for cardiovascular disease in patients with essential hypertension. Am J Hypertens 2009; 22:106-111.
5. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346:393-403.